Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom

Vaccine

Volumn 31, Issue 25, 2013, Pages 2749-2755

  Mendes, T M ^a   Oliveira, D ^a   Figueiredo, L F M ^a   Machado de Avila, R A ^a   Duarte, C G ^a   Dias Lopes, C ^a   Guimaraes G ^a   Felicori, L ^a   Minozzo, J C ^b   Chavez Olortegui C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Centro de Pesquisa e Produção de Imunobiológicos CPPI   (Brazil)

Author keywords

B cell epitopes; Dermonecrotic protein; Loxosceles spider venom; Recombinant chimeric protein

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; SPHINGOMYELIN PHOSPHODIESTERASE; SPIDER VENOM ANTISERUM;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; LOXOSCELES; LOXOSCELES INTERMEDIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; SPIDER BITE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIVENINS; EDEMA; EPITOPES, B-LYMPHOCYTE; HEMORRHAGE; NECROSIS; RABBITS; RECOMBINANT FUSION PROTEINS; SKIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPIDER VENOMS; SPIDERS;

EID: 84878353021     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.048     Document Type: Article

References (33)

1. Futrell J.M. Loxoscelism. Am J Med Sci 1992, 304:261-267.
2. Schenone H. Cutaneous loxoscelism with edematous predominance. Bol Chil Parasitol 1998, 53:78-83.
3. Tambourgi D.V., Paixao-Cavalcante D., Goncalves de Andrade R.M., Fernandes-Pedrosa Mde F., Magnoli F.C., Paul-Morgan B., et al. Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression. J Invest Dermatol 2005, 124:725-731.
4. da Silva P.H., da Silveira R.B., Appel M.H., Mangili O.C., Gremski W., Veiga S.S. Brown spiders and loxoscelism. Toxicon 2004, 44(7):693-709.
5. Hogan C.J., Barbaro K.C., Winkel K. Loxoscelism: old obstacles, new directions. Ann Emerg Med 2004, 44(6):608-624.
6. Swanson D.L., Vetter R.S. Loxoscelism. Clin Dermatol 2006, 24(3):213-221.
7. Eickstedt V.R.D. Aranhas de importância médica no Brasil. Venenos animais: uma visão integrada 1994, 151-172. EPUC, Rio de Janeiro. B. Barravieira (Ed.).
8. Ministério da Saúde Sistema Nacional de Notificação de Agravos. Ministério da saúde, Brasil; 2007.
9. Tambourgi D.V., Magnoli F.C., Von Eickstedt V.R., Benedetti Z.C., Petricevich V.L., da Silva W.D. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol 1995, 155(9):4459-4466.
10. Chaim O.M., Sade Y.B., da Silveira R.B., Toma L., Kalapothakis E., Chávez-Olortegui C., et al. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol Appl Pharmacol 2006, 211:64-77.
11. Kalapothakis E., Chatzaki M., Goncalves-Dornelas H., de Castro C.S., Silvestre F.G., Laborne F.V., et al. The Loxtox protein family in Loxosceles intermedia (Mello-Leitao) venom. Toxicon 2007, 50:938-946.
12. Fernandes-Pedrosa Mde F., Junqueira-de-Azevedo Ide L., Gonçalves-de-Andrade R.M., Kobashi L.S., Almeida D.D., Ho P.L., et al. Transcriptome analysis of Loxosceles laeta (Araneae, Sicariidae) spider venomous gland using expressed sequence tags. BMC Genomics 2008, 9:279.
13. Barbaro K.C., Eickstedt V.R., Mota I. Antigenic cross-reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil. Toxicon 1994, 32:113-120.
14. Guilherme P., Fernandes I., Barbaro K.C. Neutralization of dermonecrotic and lethal activities and differences among 32-35kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. Toxicon 2001, 39:1333-1342.
15. Alvarenga L.M., Martins M.S., Moura J.F., Kalapothakis E., Oliveira J.C., Mangili O.C., et al. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay. Toxicon 2003, 42:725-731.
16. Kalapothakis E., Araujo S.C., de Castro C.S., Mendes T.M., Gomez M.V., Mangili O.C., et al. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom. Toxicon 2002, 40:1691-1699.
17. Olvera A., Ramos-Cerrillo B., Estevez J., Clement H., de Roodt A., Paniagua-Solís J., et al. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens. Toxicon 2006, 48:64-74.
18. de Almeida D.M., Fernandes-Pedrosa Mde F., de Andrade R.M., Marcelino J.R., Gondo-Higashi H., de Azevedo Ide L., et al. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials. Am J Trop Med Hyg 2008, 79:463-470.
19. Felicori L., Araujo S.C., de Avila R.A., Sanchez E.F., Granier C., Kalapothakis E., et al. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider. Toxicon 2006, 48:509-519.
20. Felicori L., Fernandes P.B., Giusta M.S., Duarte C.G., Kalapothakis E., Nquyen C., et al. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes. Vaccine 2009, 27:4201-4208.
21. Dias-Lopes C., Guimaraes G., Felicori L., Fernandes P., Emery L., Kalapothakis E., et al. A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a 27-residue peptide. Toxicon 2010, 55:481-487.
22. de Moura J., Felicori L., Moreau V., Guimaraes G., Dias-Lopes C., Molina L., et al. Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides. Vaccine 2011, 29:7992-8001.
23. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
24. Chavez-Olortegui C., Amaral D.A., Rochat H., Diniz C., Granier C. In vivo protection against scorpion toxins by liposomal immunization. Vaccine 1991, 9(12):907-910.
25. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76(9):4350-4354.
26. Molina F., Laune D., Gougat C., Pau B., Granier C. Improved performances of Spot multiple peptide synthesis. Peptide Res 1996, 9:151-155.
27. Furlanetto W.B.R.S., Rosa R.R., Saliba F., Navas J. Observação dos efeitos do veneno loxoscélico e avaliação da sua atividade. Ciênc Cult 1962, 14:242.
28. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18(15):2714-2723.
29. Murakami M.T., Fernandes-Pedrosa M.F., Tambourgi D.V., Arni R.K. Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinases D. J Biol Chem 2005, 280(14):13658-13664.
30. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000, 29:291-325.
31. Theakston R.D.G., Warrell D.A., Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003, 41:541-557.
32. Wagstaff S.C., Laing G.D., Theakston R.D.G., Papaspuridis C., Harrison R.A. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom. PLoS Med 2006, 3(6):832-839.
33. Binford G.J., Bodner M.R., Cordes M.H., Baldwin K.L., Rynerson M.R., Burns S.N., et al. Molecular evolution, functional variation, and proposed nomenclature of the gene family that includes sphingomyelinase D in sicariid spider venoms. Mol Biol Evol 2009, 26:547-566.